Champions Oncology Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BATTERY MANAGEMENT CORP. | 02/17/2026 | 2.42 M | $16.73 M | 0.00% | 17.56% |
| NEA MANAGEMENT COMPANY, LLC | 02/17/2026 | 1.71 M | $11.84 M | 0.00% | 12.43% |
| VANGUARD GROUP INC | 01/29/2026 | 334.61 K | $2.31 M | 0.40% | 2.43% |
| TOCQUEVILLE ASSET MANAGEMENT L.P. | 02/12/2026 | 319.67 K | $2.21 M | 0.00% | 2.32% |
| MORGAN STANLEY | 02/13/2026 | 229.66 K | $1.59 M | 21.13% | 1.67% |
| RENAISSANCE TECHNOLOGIES LLC | 02/12/2026 | 154.84 K | $1.07 M | -7.43% | 1.12% |
| BLACKROCK, INC. | 02/12/2026 | 122.77 K | $848.35 K | 0.71% | 0.89% |
| MINK BROOK ASSET MANAGEMENT LLC | 02/13/2026 | 80.31 K | $554.91 K | 100.00% | 0.58% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/09/2026 | 75.82 K | $524.02 K | 1.89% | 0.55% |
| NORTHERN TRUST CORP | 02/17/2026 | 46.15 K | $318.87 K | -0.62% | 0.33% |
| JANE STREET GROUP, LLC | 02/12/2026 | 36.10 K | $249.45 K | 100.00% | 0.26% |
| HIGHTOWER ADVISORS, LLC | 02/06/2026 | 35.16 K | $242.94 K | 0.00% | 0.25% |
| ACADIAN ASSET MANAGEMENT LLC | 02/10/2026 | 30.00 K | $206.00 K | -17.10% | 0.22% |
| BANK OF NEW YORK MELLON CORP | 02/10/2026 | 26.75 K | $184.84 K | 0.00% | 0.19% |
| STATE STREET CORP | 02/13/2026 | 26.20 K | $181.06 K | 0.00% | 0.19% |
| DIMENSIONAL FUND ADVISORS LP | 02/12/2026 | 25.35 K | $174.88 K | 6.97% | 0.18% |
| BANK OF AMERICA CORP /DE/ | 02/17/2026 | 21.99 K | $151.92 K | 0.96% | 0.16% |
| GSA CAPITAL PARTNERS LLP | 02/06/2026 | 20.98 K | $145.00 K | 101.42% | 0.15% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 02/13/2026 | 18.25 K | $126.10 K | 100.00% | 0.13% |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | 02/11/2026 | 13.03 K | $90.04 K | -9.93% | 0.09% |
| CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. | 02/05/2026 | 12.25 K | $85.00 K | 0.00% | 0.09% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT, INC. | 02/05/2026 | 10.30 K | $71.17 K | -14.17% | 0.07% |
| MILLENNIUM MANAGEMENT LLC | 02/17/2026 | 10.20 K | $70.50 K | -19.25% | 0.07% |
| WHITTIER TRUST CO | 01/26/2026 | 800 | $5.29 K | 0.00% | 0.01% |
| UBS GROUP AG | 01/29/2026 | 190 | $1.31 K | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 02/11/2026 | 11 | $76 | 0.00% | 0.00% |
| SBI SECURITIES CO., LTD. | 02/03/2026 | 4 | $28 | -75.00% | 0.00% |
| ROYAL BANK OF CANADA | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Champions Oncology Inc institutional Ownership - FAQ's
During the previous two years, 39 institutional investors and hedge funds held shares of Champions Oncology Inc. The most heavily invested institutionals were:
TOCQUEVILLE ASSET MANAGEMENT L.P.: 319,674
Mink Brook Asset Management LLC: 111,338
HighTower Advisors, LLC: 35,158
VANGUARD FIDUCIARY TRUST CO: 32,992
DIMENSIONAL FUND ADVISORS LP: 23,973
Bank of New York Mellon Corp: 21,614
41.70% of Champions Oncology Inc stock is owned by institutional investors.
Institutional investors have bought a total of 8.39 M shares in the last 24 months. This purchase volume represents approximately $49.69 M in transactions.